Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice
- PMID: 7783752
- DOI: 10.1016/0161-5890(95)00024-9
Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice
Abstract
The nature of the stimuli driving autoantibody production in systemic lupus erythematosus (SLE) is unclear, but cytokines are believed to play an important role. Since cytokines primarily appear to act locally at the tissue level, we analysed mRNA expression of several cytokines (IL-1 alpha, IL-1 beta, IL-2, IL-4, IL-5, IL-6, IL-10, IFN gamma, TNF alpha, TNF beta and TGF beta 1) in the lymph nodes of lupus-prone mice, in models of early onset disease. We constructed a multispecific competitor fragment that allowed quantification of these cytokine transcripts by competitive PCR assay. The results reveal considerable overexpression of IL-1 beta, IL-10 and IFN gamma transcripts in SLE-prone MRL-lpr/lpr (MRL/l) and BXSB male (BXSBm) mice, but with some strain differences. IFN gamma was most markedly augmented in MRL/l mice (in some cases over 100-fold greater than control mice), IL-1 beta was most severely overexpressed in BXSBm mice while IL-10 was equally increased in both strains. In addition, TGF beta 1 expression was moderately elevated in the lymph nodes of BXSBm (but not MRL/l) mice. We found no abnormality in the expression of the other cytokines. Cytokine transcript levels were only slightly altered at 4 weeks of age, but were elevated from 10 to 22 weeks of age. The latter phase corresponds to a period where lupus-like disease escalates, resulting in frequent mortality. Interestingly, our results do not reveal a clear Th1 or Th2 cytokine expression pattern in these lupus-prone mice. IL-1 beta, IFN gamma and IL-10 are pleiotropic cytokines with pro-inflammatory and B-cell stimulatory effects. These results point to certain cytokines as potential targets for immunotherapy in lupus.
Similar articles
-
Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.J Clin Invest. 1996 Apr 1;97(7):1597-604. doi: 10.1172/JCI118584. J Clin Invest. 1996. PMID: 8601623 Free PMC article.
-
Cytokine gene expression in the MRL/lpr model of lupus nephritis.Kidney Int. 1996 Jul;50(1):85-93. doi: 10.1038/ki.1996.290. Kidney Int. 1996. PMID: 8807576
-
Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.Gut. 1997 Dec;41(6):793-800. doi: 10.1136/gut.41.6.793. Gut. 1997. PMID: 9462212 Free PMC article.
-
Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.J Biomed Biotechnol. 2010;2010:461641. doi: 10.1155/2010/461641. Epub 2010 Aug 17. J Biomed Biotechnol. 2010. PMID: 20827419 Free PMC article. Review.
-
Roles of IL-1 and IL-10 family cytokines in the progression of systemic lupus erythematosus: Friends or foes?IUBMB Life. 2022 Feb;74(2):143-156. doi: 10.1002/iub.2568. Epub 2021 Oct 19. IUBMB Life. 2022. PMID: 34668305 Review.
Cited by
-
Mercury exposure, serum antinuclear/antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: a cross-sectional study.Environ Res. 2010 May;110(4):345-54. doi: 10.1016/j.envres.2010.02.001. Epub 2010 Feb 21. Environ Res. 2010. PMID: 20176347 Free PMC article.
-
Enhanced expression of interferon-inducible protein 10 associated with Th1 profiles of chemokine receptor in autoimmune pulmonary inflammation of MRL/lpr mice.Arthritis Res Ther. 2004;6(1):R78-R86. doi: 10.1186/ar1029. Epub 2003 Nov 19. Arthritis Res Ther. 2004. PMID: 14979941 Free PMC article.
-
Tumour necrosis factor and other cytokines in murine lupus.Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I49-55. doi: 10.1136/ard.58.2008.i49. Ann Rheum Dis. 1999. PMID: 10577973 Free PMC article. Review. No abstract available.
-
Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage.Immunity. 2010 Dec 14;33(6):967-78. doi: 10.1016/j.immuni.2010.11.025. Immunity. 2010. PMID: 21167752 Free PMC article.
-
The dysregulation of cytokine networks in systemic lupus erythematosus.J Interferon Cytokine Res. 2011 Oct;31(10):769-79. doi: 10.1089/jir.2011.0029. Epub 2011 Aug 30. J Interferon Cytokine Res. 2011. PMID: 21877904 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases